
Kies je etiket
direct zichtbaar op de vialOvagen
Bioregulators
- Verzonden vanuit Duitsland
Bestelling
- DHL met tracking
- Discrete verpakking
In één oogopslag
Ovagen in cijfers
De kerncijfers uit ons lexicon.
Volledig lexiconartikel- Class
- Short bioregulator peptideKhavinson cytogen
- Use
- Subcutaneousin mg
- Sizes
- 20 mg1 size in the shop
What studies show
The source in the lexiconPeptides and aging: review of tissue-specific bioregulators (Khavinson program) (opens in a new tab)
Khavinson, Neuro Endocrinology Letters, 2002
Er is nog geen labanalyse voor Ovagen. Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses
Kennis
Alles over Ovagen
Uitgebreide informatie volgt binnenkort.
Dosering
Doseringsinformatie laden …
Handig om erbij te hebben
Wat je erbij nodig hebt
Bacteriostatisch water wordt automatisch aan je winkelwagen toegevoegd. Spuiten en doekjes met één klik.
Insulinespuiten
10 stuks · 5.50 €
Alcoholdoekjes
50 stuks · 10 €
Hoeveel water?
Eenheden op de spuit voor jouw vialgrootte.
Naar de calculator →What is Ovagen?
According to a review by the Khavinson group, the tripeptide Glu-Asp-Leu (EDL). The group lists it as a protective peptide for the kidneys and liver. PubMed has no study under the name Ovagen, the papers call it EDL or T-35.
What do the studies on EDL show?
In rats with kidney damage from the antibiotic gentamicin or from interrupted blood flow, EDL prevented a drop in urine output and a build-up of waste products. Protein and sodium in the urine fell, antioxidant enzymes did not drop critically. The abstract gives no percentages.
How well is the effect on the liver supported?
Weakly. For the liver the review cites a patent of the group as evidence, no published study with EDL in the liver was found. The related short peptide Livagen stimulated the growth of liver tissue pieces in tissue culture.
How is Ovagen supposed to work?
The Khavinson group suggests that short peptides reach the cell nucleus and bind to DNA. Modelled on the computer, EDL bound the same DNA sequence as Bronchogen and could enter cells via the transporter LAT1. In kidney cell cultures the enzyme MMP-14 was its target. This is only shown in models and cell cultures.
Has Ovagen been studied in humans?
No. ClinicalTrials.gov lists no trial with Ovagen or EDL (as of 26 Oct 2026). The 2002 review describes clinical use of tissue extracts such as Epithalamin and Thymalin, not of Ovagen.
Which side effects are known?
There are no solid data because Ovagen has never been tested in a registered human trial. Missing reports are not proof of safety.
Gerelateerd
Gerelateerde producten
Bronchogen
Peptiden · Specialiteiten & ondersteuning Specialiteiten & ondersteuning
1 maat
= 32 €/vial
Cardiogen
Peptiden · Specialiteiten & ondersteuning Specialiteiten & ondersteuning
1 maat
= 32 €/vial
Cortagen
Peptiden · Specialiteiten & ondersteuning Specialiteiten & ondersteuning
1 maat
= 32 €/vial
Chonluten
Peptiden · Specialiteiten & ondersteuning Specialiteiten & ondersteuning
1 maat
= 32 €/vial
Ovagen